Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 762 of 6351
-
New hope for hodgkin lymphoma: targeted drug combo shows promise in early trial
Disease control Recruiting nowThe purpose of this study is to test whether BV-AVD is an effective treatment in people with early stage, bulky Hodgkin lymphoma that was recently diagnosed and who have not yet received any treatments for their disease. BV is a type of drug called an antibody-drug conjugate (AD…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can this drug fully heal the gut in Crohn's?
Disease control OngoingThe purpose of this study is to evaluate the efficacy of guselkumab in healing of all layers of the digestive tract (transmural healing) with the help of a score called Magnetic Resonance Index of Activity (MaRIA) based on a scan at Week 48.
Phase 3 • Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug shows promise for Tough-to-Treat stomach cancer
Disease control CompletedThe study is a open-label, single-arm, multicenter, phase Ib/II trial assessing the efficacy of sacituzumab-govitecan for metastatic esophagogastric adenocarcinoma
Phase 1/2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Gut bacteria pill could boost stomach cancer treatment
Disease control Recruiting nowThis is a randomized non-comparative, multicenter phase II study in patients with PD-L1 PD-L1 combined positive score (CPS) ≥5 advanced gastric cancer to evaluate the efficacy and safety of nivolumab and FOLFOX in combination with EXL01 as first-line treatment. After signing the…
Phase 2 • Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug targets tough cancers with specific gene flaw
Disease control Stopped earlyGenes contain genetic code which tell the body which proteins to make. Some types of cancer are caused by changes, or mutations, in a gene called KRAS. Researchers are looking for ways to stop the actions of abnormal proteins made from the mutated KRAS gene. The so-called G12D mu…
Phase 1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Tailored radiation may spare neck tissues in nasopharyngeal cancer
Disease control Recruiting nowTo evaluate whether individualized elective neck irradiation for nasopharyngeal carcinoma based on the vertebral level of metastatic lymph nodes can reduce the incidence of radiation-related adverse effects and improve patients' quality of life,without reducing survival.
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC
-
New device aims to seal brain aneurysms without open surgery
Disease control Recruiting nowThe purpose of this study is to assess the safety and effectiveness of the Artisse™ Intrasaccular Device in the treatment of unruptured and ruptured wide-neck bifurcating intracranial aneurysms.
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Magic mushroom therapy targets Cancer-Related depression
Symptom relief Recruiting nowTo learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy on depression and/or anxiety in participants who are being treated for advanced cancer.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can prostate cancer patients skip hormone therapy? new trial tests SBRT alone
Disease control Recruiting nowFor this study, unfavorable intermediate risk prostate cancer patients will select whether they are to be treated with the standard of care (SOC) 6 months of Androgen Deprivation Therapy (ADT) in conjunction with stereotactic body radiation therapy/radiosurgery (SBRT) directed to…
Phase 2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New CAR-T therapy targets Tough-to-Treat lymphomas
Disease control OngoingPhase 1 study comprised of open-label, dose escalation and expansion cohort study of P-CD19CD20-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in subjects with relapsed/refractory B cell malignancies
Phase 1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug vs. brain stimulation: which stops suicidal thoughts faster?
Symptom relief CompletedThis study is a multicenter, randomized, non-inferiority, parallel-group clinical trial designed to evaluate the efficacy and safety of esketamine compared with electroconvulsive therapy (ECT) in the treatment of suicidal ideation during depressive episodes in patients with mood …
Sponsor: Capital Medical University • Aim: Symptom relief
Last updated Jun 26, 2026 13:46 UTC
-
Hope for rare Muscle-Weakening disease: new drug trial targets Antibody-Negative patients
Disease control OngoingThe primary purpose of this study is to measure the efficacy and safety of efgartigimod IV compared to placebo in participants with Acetylcholine Receptor Binding Antibody (AChR-Ab) seronegative Generalized Myasthenia Gravis (gMG). The study consists of a Part A where participant…
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could your own fat cells heal a damaged brain?
Disease control Recruiting nowThe global objective of this study is to establish the safety and investigate the potential treatment effect of an intravenous infusion of HB-adMSCs (Hope Biosciences adipose-derived mesenchymal stem cells) on brain structure, neurocognitive/functional outcomes, and neuroinflamma…
Phase 2 • Sponsor: Hope Biosciences LLC • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug duo aims to halt stomach cancer spread
Disease control Recruiting nowThis study is being done to answer the following question: Can the chance of gastroesophageal cancer growing or spreading be lowered by adding a drug called zanidatamab to the usual combination of drugs? We are doing this study because we want to find out if this approach is be…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Custom-Made genetic drug takes aim at rare form of ALS
Disease control OngoingThis research project entails delivery of a personalized antisense oligonucleotide (ASO) drug designed for a single participant with amyotrophic lateral sclerosis (ALS) due to a pathogenic variant in CHCHD10
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a special PET scan see bladder cancer more clearly?
Diagnosis Recruiting nowMIBC-PET is a prospective, monocentric, no-profit study with paired imaging comparison enrolling 60 patients with newly diagnosed, histologically confirmed high-grade MIBC. All patients undergo baseline staging with \[18F\]FDG PET/CT and contrast-enhanced CT (ceCT) of chest, abdo…
Sponsor: University Hospital of Ferrara • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Can microwave ablation outperform radiofrequency for thyroid nodules?
Disease control Recruiting nowThyroid nodule is a common condition that affects up to 60% of the population. There is an estimated 10% lifetime probability of developing a thyroid nodule. Although most thyroid nodules are benign, up to 10-15% can enlarge to cause compressive symptoms including neck pressure a…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for scleroderma lung disease: major trial underway
Disease control Recruiting nowThe goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung capacity in participants with Interstitial Lung Disease Secondary to Systemic Sc…
Phase 2 • Sponsor: Scleroderma Research Foundation, Inc. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New combo therapy shows promise for shrinking lung tumors before surgery
Disease control OngoingThis study aimed to evaluate the efficacy and safety of Toripalimab injection (js001) combined with SBRT radiotherapy and neoadjuvant therapy with or without chemotherapy for operable or potentially operable stage IIa to IIIb NSCLC
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a simple blood test finally diagnose TB in kids?
Diagnosis Recruiting nowPediatric tuberculosis (TB) continues to pose diagnostic challenges in low- and middle-income countries with high rates of TB disease, due to the well-described impact of paucibacillary disease in children, and current TB culture and polymerase-chain reaction tests are of limited…
Sponsor: Tulane University • Aim: Diagnosis
Last updated Jun 26, 2026 13:32 UTC